H. Kato et al., Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: A study using TNP-470, JPN J CANC, 92(1), 2001, pp. 67-73
We established peritoneal dissemination-prone subcultures (PCI-43p3) using
nude mice by a repetitive in vivo selection of intraperitoneally inoculated
PCI-43, a pancreas adenocarcinoma cell line. The subcultures showed upregu
lated expression of matrix metalloproteinase (MMP)-9, but not MMP-2 in cult
ure supernatants, They also produced increased amounts of vascular endothel
ial growth factor (VEGF), which was not associated with alterations in isof
orms of VEGF mRNA, PCI-43p3 cells attached to cultured mesothelial cell mon
olayers more readily than did the parent PCI-43 tells. The angiogenesis inh
ibiting agent, TNP-470, at 30 mg/kg was administered to the model mice, res
ulting in a prominent suppression of the establishment of peritoneal nodule
s, The suppression was dependent on the duration of TNP-470 treatment. TNP-
470 treatment significantly suppressed proliferation of tumor cells in diss
eminated nodules, assessed in terms of immunostaining for proliferating cel
l nuclear antigen (PCNA), TNP-470 did not affect the in vitro attachment be
tween PCI-43p3 and mesothelial cells. The combined data show that anti-angi
ogenic treatment profoundly suppresses the in vivo process of peritoneal di
ssemination.